# Molecular farming for food Genetically engineered food crops — pea, potato, soybean, tobacco — are being turned into biofactories for specific animal-identical proteins (myoglobin, ovalbumin, casein, thaumatin), aiming to reach USDA/FDA and EFSA approval as a plant-grown alternative to fermentation or cell culture. Source: https://en.bioecon.ru/technology/molecular-farming-for-food/ Updated: 2026-08-18 ## Overview and value chain Markers: [EC: USDA/FDA plant-made protein approval pathway | OECD: Food systems | Regulator: FDA (USA), EFSA (EU)] Molecular farming for food genetically engineers ordinary food crops to express a single target animal protein directly in the seed or tuber, turning the plant itself into the production bioreactor rather than a fermentation tank or a bioreactor of cultured cells. Moolec Science announced a molecular-farming breakthrough in April 2026, successfully expressing bovine myoglobin — an iron-rich, heme-containing protein — in pea seeds. PoLoPo has filed for USDA approval of its SuperAA platform, which genetically engineers potatoes to produce the egg proteins patatin and ovalbumin. Mozza Foods is targeting a late-2028 launch of soybean-grown casein, pending USDA approval to grow the genetically modified crop and FDA approval to sell the extracted dairy protein — illustrating how the regulatory timeline, not the plant biology, is now the sector's critical path. Nomad Bioscience already has secured US regulatory approval for one plant-made product, Thaumatin II, a natural super-sweet protein, commercialized through its NAMBAWAN Biotech food-market spin-off. Key directions of molecular farming for food: 1. **Animal-identical protein expression in seed crops (Animal-Identical Protein Expression in Seed Crops):** engineering pea, soy or other seed crops to express a specific animal protein (myoglobin, casein) at harvest-ready scale. 2. **Tuber-based egg-protein production (Tuber-Based Egg-Protein Production):** engineering potatoes to produce named egg proteins (patatin, ovalbumin) as a plant-grown egg-replacement platform. 3. **Sweet/functional protein commercialization (Sweet/Functional Protein Commercialization):** plant-made specialty proteins (natural sweeteners like thaumatin) reaching market through a dedicated food-market spin-off ahead of the sector's animal-protein-replacement products. 4. **Dual USDA/FDA regulatory gating (Dual USDA/FDA Regulatory Gating):** molecular-farming food products need both a GM-crop cultivation approval (USDA) and a food-ingredient sale approval (FDA), a two-step gate distinct from single-agency review in fermentation or cell-culture proteins. ### Sectoral value chain ``` [target protein selection] ──> [crop genetic engineering] ──> [field/greenhouse cultivation] ──> [protein extraction] │ (dual USDA/FDA regulatory review) │ ▼ [food ingredient sale] <─── [purification & formulation] <───────────┘ ``` ### Value chain levels | Level | Description | Key inputs/outputs | |:---|:---|:---| | **Target Protein Selection** | choosing the animal-identical protein to express (myoglobin, ovalbumin, casein) | **In:** target protein sequence. **Out:** expression construct. | | **Crop Genetic Engineering** | inserting the expression construct into the host crop's genome | **In:** host crop, construct. **Out:** transgenic seed/tuber line. | | **Field/Greenhouse Cultivation** | growing the engineered crop to harvest under regulated conditions | **In:** transgenic seed, growing conditions. **Out:** harvested biomass. | | **Protein Extraction** | extracting and purifying the target protein from the harvested crop | **In:** harvested biomass. **Out:** crude protein extract. | | **Purification & Formulation** | refining the extract into a food-grade ingredient | **In:** crude extract. **Out:** formulated food ingredient. | | **Food Ingredient Sale** | selling the cleared ingredient into food manufacturing | **In:** formulated ingredient. **Out:** revenue. | Cross-cutting technologies of the sector: - **Seed/tuber-specific promoter engineering (Seed/Tuber-Specific Promoter Engineering):** genetic constructs that direct target-protein expression specifically to the harvestable seed or tuber tissue. - **Heme/iron-protein plant expression (Heme/Iron-Protein Plant Expression):** engineering plants to fold and accumulate iron-containing proteins like myoglobin, historically difficult outside animal or microbial hosts. - **Dual-agency regulatory dossier design (Dual-Agency Regulatory Dossier Design):** structuring a single molecular-farming product's evidence package to satisfy both a crop-cultivation regulator and a food-ingredient regulator. --- ## US The US is the site of the sector's most advanced regulatory filing and a second entrant with a firm public product-launch timeline. ### USDA/FDA dual filings, soybean-grown casein timeline, GM-crop cultivation approval - **Mozza Foods:** a California-based molecular-farming startup targeting a late-2028 launch of soybean-grown casein, pending USDA approval to grow the GM soybean crop and FDA approval to sell the extracted dairy protein. - **Regulatory sequencing as the critical path:** the multi-year gap between scientific proof-of-concept and Mozza's targeted launch date reflects the dual-agency approval sequence as the sector's dominant timeline constraint, not the underlying plant science. --- ## CN Public information on a dedicated Chinese molecular-farming-for-food originator was not confirmed in this pass; the section stays at the policy level. ### no confirmed flagship originator, recombinant-protein reagent supply base, regulatory pathway undefined - **No confirmed flagship originator:** a Chinese company engineering food crops specifically to express animal-identical proteins for commercial food sale was not confirmed via live sources in this pass. - **Existing recombinant-protein reagent supply:** China has an established recombinant-protein reagent and research-grade supply industry, though this pass found no evidence it has extended into food-grade molecular farming. - **Regulatory pathway undefined:** no China-specific dual-agency (crop cultivation plus food-ingredient) approval framework for molecular-farmed food proteins was confirmed in this pass. --- ## EU Europe and its adjacent originators (Argentina-rooted, Israel-based, and a German recombinant-protein specialist) supply three of the sector's most advanced molecular-farming programs. ### pea-seed myoglobin breakthrough, potato egg-protein platform, secured US approval for a plant-made sweetener - **Moolec Science:** announced a molecular-farming breakthrough in April 2026, successfully expressing bovine myoglobin in pea seeds — a heme-containing, iron-rich protein historically difficult to produce outside an animal host. - **PoLoPo:** filed for USDA approval of its SuperAA platform, which genetically engineers potatoes to produce the egg proteins patatin and ovalbumin as a plant-grown egg-replacement ingredient. - **Nomad Bioscience:** already holds secured US regulatory approval for Thaumatin II, a natural super-sweet plant-made protein, commercialized through its NAMBAWAN Biotech food-market spin-off, with approvals in other countries pending. --- ## Leading companies and research institutes | Company / Institute | Country | Key products / platforms | Tech features | Status 2026 | |:---|:---|:---|:---|:---| | **Moolec Science** | 🇦🇷 Argentina | *Bovine myoglobin in pea seeds* | NASDAQ: MLEC; heme-protein plant expression | Commercial | | **PoLoPo** | 🇮🇱 Israel | *SuperAA potato egg-protein platform* | patatin/ovalbumin expression; filed for USDA approval | Growth | | **Mozza Foods** | 🇺🇸 USA | *Soybean-grown casein* | targeting late-2028 launch pending USDA/FDA approval | Growth | | **Nomad Bioscience** | 🇩🇪 Germany | *Thaumatin II (NAMBAWAN Biotech)* | secured US approval; natural super-sweet protein | Commercial | --- ## Tech stack and innovations The stack turns crop genetic engineering into a food-protein production system. 1. **Seed/tuber-specific expression engineering (Seed/Tuber-Specific Expression Engineering):** - genetic constructs direct protein accumulation specifically to the harvestable seed or tuber rather than the whole plant. - case: PoLoPo's SuperAA platform expresses named egg proteins specifically in potato tubers. 2. **Heme-protein plant folding (Heme-Protein Plant Folding):** - plants are engineered to correctly fold and accumulate iron-containing heme proteins, a historically difficult target outside animal/microbial hosts. - case: Moolec Science's successful bovine myoglobin expression in pea seeds is described as a molecular-farming breakthrough specifically because of this folding challenge. 3. **Dual-agency regulatory dossier structuring (Dual-Agency Regulatory Dossier Structuring):** - a single product's evidence package is built to satisfy both a crop-cultivation regulator (USDA) and a food-ingredient regulator (FDA) in sequence. - case: Mozza Foods' soybean-grown casein timeline is explicitly paced by this two-step approval sequence rather than by production scale-up. --- ## Value chains and production pipelines ### Industrial pipeline of a molecular-farmed food protein (dual USDA/FDA review) ``` ┌───────────────────────────┐ ┌───────────────────────────┐ │ 1. Target protein selection│ ───> │ 2. Crop genetic engineering│ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 4. Protein extraction │ <─── │ 3. Field/greenhouse cultivation│ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 5. Dual regulatory review │ ───> │ 6. Food ingredient launch │ └───────────────────────────┘ └───────────────────────────┘ ``` #### Stage 1: Target protein selection An animal-identical protein sequence (myoglobin, ovalbumin, casein, thaumatin) is selected for plant expression. #### Stage 2: Crop genetic engineering The expression construct, with a seed- or tuber-specific promoter, is inserted into the host crop's genome. #### Stage 3: Field/greenhouse cultivation The transgenic crop is grown to harvest under regulated field or greenhouse conditions. #### Stage 4: Protein extraction The target protein is extracted and purified from the harvested seed or tuber biomass. #### Stage 5: Dual regulatory review The product clears both a crop-cultivation approval (USDA) and a food-ingredient sale approval (FDA), or the EFSA equivalent in the EU. #### Stage 6: Food ingredient launch The cleared ingredient enters food manufacturing; Nomad Bioscience's Thaumatin II has already reached this stage in the US, while Mozza Foods and PoLoPo are still working through Stage 5.